LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 15.58 | 27.76 | 1052 | 685 | 1.5345 | 1.1940 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 17.28 | 27.76 | 1074 | 838 | 1.2805 | 1.1031 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 17.28 | 27.76 | 1154 | 838 | 1.3759 | 1.1341 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 17.28 | 27.76 | 11 | 838 | 0.0131 | -0.1716 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 17.28 | 27.76 | 1140 | 838 | 1.3592 | 1.1288 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 18.98 | 27.76 | 986 | 941 | 1.0477 | 1.0184 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 18.98 | 27.76 | 1082 | 941 | 1.1497 | 1.0556 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 18.98 | 27.76 | 9 | 941 | 0.0096 | -0.1987 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 18.98 | 27.76 | 1025 | 941 | 1.0891 | 1.0339 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 20.68 | 27.76 | 905 | 1119 | 0.8088 | 0.9220 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 20.68 | 27.76 | 955 | 1119 | 0.8534 | 0.9414 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 20.68 | 27.76 | 18 | 1119 | 0.0161 | -0.0780 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 20.68 | 27.76 | 1003 | 1119 | 0.8963 | 0.9594 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 22.39 | 27.76 | 1037 | 1305 | 0.7942 | 0.9188 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 22.39 | 27.76 | 1064 | 1305 | 0.8149 | 0.9277 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 22.39 | 27.76 | 23 | 1305 | 0.0176 | -0.0333 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 22.39 | 27.76 | 1100 | 1305 | 0.8425 | 0.9392 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 24.09 | 27.76 | 986 | 1461 | 0.6746 | 0.8670 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 24.09 | 27.76 | 1008 | 1461 | 0.6896 | 0.8742 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 24.09 | 27.76 | 29 | 1461 | 0.0198 | 0.0077 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 24.09 | 27.76 | 977 | 1461 | 0.6684 | 0.8640 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 25.79 | 27.76 | 958 | 1605 | 0.5968 | 0.8312 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 25.79 | 27.76 | 970 | 1605 | 0.6043 | 0.8351 | MN20160318_Q01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 25.79 | 27.76 | 28 | 1605 | 0.0174 | 0.0015 | MN20160318_Q01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 25.79 | 27.76 | 960 | 1605 | 0.5981 | 0.8319 | MN20160318_Q01 | L13 |